Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001250853-14-000094
Filing Date
2014-07-29
Accepted
2014-07-29 21:00:20
Documents
1
Period of Report
2014-07-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1485
  Complete submission text file 0001250853-14-000094.txt   3154
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4640 SW MACADAM AVE STE 270 PORTLAND OR 97239
Business Address
Kivinski Margaret (Reporting) CIK: 0001615171 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33958 | Film No.: 141001060